Have any question? Call Us Now?

    Stem Cell Therapy for ARMD in Nigeria: how to read research claims

    Reports of stem cell breakthroughs for ARMD can be confusing. This page explains what trial results actually measure so you can judge claims calmly.

    Stem cell therapy for ARMD in Nigeria

    What does improved really mean

    Headlines may say vision improved, but trials usually track specific measures: the area of lost tissue, letters read on a chart, or reading speed. A small gain on an eye chart can still matter in daily life, but it is not the same as normal sight.

    Understanding the measure helps you ask better questions and avoid being misled by hopeful wording.

    Measures worth asking about

    Each tells a different story.

    • Letters read on a chartShows central sharpness.
    • Area of tissue lossMeasured by imaging and tracked over time.
    • Reading speedPractical test of everyday function.
    • Safety eventsRecords inflammation, bleeding or detachment.
    • Length of follow-upShort studies may miss late problems.

    Where cell therapy for ARMD stands

    A realistic summary.

    Early human studies

    Some report cell survival and acceptable safety.

    Mixed visual results

    Gains differ from person to person.

    Surgery required

    Placing cells under the retina is a delicate operation.

    Not standard care

    Established treatments such as injections continue.

    Talking to your own eye doctor

    A partnership is safest.

    Share your scans

    Your local specialist should see any proposed plan.

    Ask about alternatives

    Know what standard options remain.

    Understand follow-up

    Plan who will monitor you afterwards.

    Take your time

    No decision should be rushed.

    Words you will see in trial reports

    Understanding the vocabulary makes research easier to follow.

    • Phase 1Tests safety in a small group.
    • Phase 2Looks for early signs of benefit.
    • RandomisedParticipants are placed in groups by chance.
    • EndpointThe main result a trial is designed to measure.

    Our Medical Experts – Trusted Specialists

    Eye Stem Cell Center brings together pioneers in stem cell biotechnology and highly experienced ophthalmologists to provide advanced regenerative eye care with compassion and precision.

    Dr. Pallavi

    Senior Consultant | Ophthalmologist & Eye Surgeon 22+ Years Experience

    Dr. Pallavi is renowned for her expertise in cataract and corneal surgeries. With thousands of successful procedures, she combines surgical precision with a patient‑first approach.

    Get Consultation

    Dr. Robin

    Consultant Ophthalmologist & Eye Surgeon | MD, DO 16+ Years Experience

    Dr. Robin specializes in advanced cataract surgery, refractive procedures, and keratoconus treatment. His clinical excellence ensures patients receive world‑class eye care.

    Get Consultation

    Dr. Pawan

    Associate Professor | Vitreo-Retina Surgeon 10+ Years Experience

    Dr. Pawan is an expert in retinal disorders, diabetic retinopathy, and advanced retina procedures. His patient‑focused approach ensures precise treatment and long‑term vision care.

    Get Consultation

    Frequently asked questions

    Can stem cells fix dry ARMD?

    They are being studied for advanced dry ARMD, but no cure has been shown.

    Does a trial result apply to me?

    Only if you resemble the participants in stage and eye health.

    Should I stop my injections?

    No. Keep them as advised while you gather information.

    Our Customer Experiences

    Query form


      Translate »